Active immunotherapy with B.C.G. for melanoma.
D000276:Adjuvants, Immunologic; D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine